Latest News about ABCL
Recent news which mentions ABCL
The 7 Best-Performing ETFs Money Can Buy In 2021
April 21, 2021
From InvestorPlace
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
April 15, 2021
From Benzinga
From Benzinga
From Benzinga
71 Biggest Movers From Yesterday
April 01, 2021
From Benzinga
66 Biggest Movers From Yesterday
March 31, 2021
From Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
March 30, 2021
From Benzinga
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
March 30, 2021
From Benzinga
33 Stocks Moving in Tuesday's Pre-Market Session
March 30, 2021
From Benzinga
8 Stocks Moving In Monday's After-Hours Session
March 29, 2021
From Benzinga
5 Stocks To Watch For March 29, 2021
March 29, 2021
From Benzinga
Earnings Scheduled For March 29, 2021
March 29, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Friday
March 26, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Friday
March 05, 2021
From Benzinga
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
March 05, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 04, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
February 24, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 23, 2021
From Benzinga
Why AzurRx BioPharma, Usana Health Are Moving Today
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
Code red — here’s what it means for the stock market now that company insiders are selling shares
February 04, 2021
From MarketWatch
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
January 12, 2021
From Benzinga
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 06, 2021
From Benzinga
Benzinga's Top Upgrades, Downgrades For January 5, 2021
January 05, 2021
From Benzinga
The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
December 30, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 29, 2020
From Benzinga
Why Is It Moving? Analyzing The Downward Movement in AbCellera Biologics's Stock Today
December 29, 2020
Tickers
ABCL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.